Biotechnology & Medical Research

Zealand Pharma A/S maintains FY 2014 financial guidance

Zealand Pharma A/S:Says expects FY 2014 revenue from milestone payments of 133 million Danish crowns.Says net operating expenses in FY 2014 are expected at a range of 195 million Danish crowns.

Friday, 22 Aug 2014 02:30am EDT

BioSpecifics Technologies Corp announces positive data from Phase 2a study of CCH for treatment of Cellulite

BioSpecifics Technologies Corp:Says positive, statistically results from randomized, double-blind Phase 2a study of CCH for potential treatment of cellulite, or edematous fibrosclerotic panniculopathy.Results showed that all three doses of CCH used in the study, including low, medium and high dose,...

Thursday, 21 Aug 2014 05:36pm EDT

OncoGenex Pharmaceuticals Inc announces update on phase 3 ENSPIRIT trial evaluating Custirsen in advanced non-small cell lung cancer

OncoGenex Pharmaceuticals Inc:Says Phase 3 ENSPIRIT trial, evaluating custirsen in treatment of non-small cell lung cancer (NSCLC), is continuing as planned per recommendation of Independent Data Monitoring Committee (IDMC) based upon completion of first interim futility analysis.

Thursday, 21 Aug 2014 04:00pm EDT

Galena Biopharma appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer

Galena Biopharma Inc:Appoints Mark W. Schwartz, Ph.D as President and Chief Executive Officer, effective immediately.Replaces Mark J. Ahn, Ph.D. who has resigned as the President and CEO and as a director.

Thursday, 21 Aug 2014 07:05am EDT

Mergers & Acquisitions


  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.